Cargando…

Safety and Efficacy of Antibiotic De-escalation and Discontinuation in High-Risk Hematological Patients With Febrile Neutropenia: A Single-Center Experience

BACKGROUND: There is currently no consensus on optimal duration of antibiotic treatment in febrile neutropenia. We report on the clinical impact of implementation of antibiotic de-escalation and discontinuation strategies based on the Fourth European Conference on Infections in Leukaemia (ECIL-4) re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verlinden, Anke, Jansens, Hilde, Goossens, Herman, Anguille, Sébastien, Berneman, Zwi N, Schroyens, Wilfried A, Gadisseur, Alain P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826378/ https://www.ncbi.nlm.nih.gov/pubmed/35146042 http://dx.doi.org/10.1093/ofid/ofab624

Ejemplares similares

Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change
por: Mebis, J, et al.
Publicado: (2010)

Comparison of the Power of Procalcitonin and C-Reactive Protein to Discriminate between Different Aetiologies of Fever in Prolonged Profound Neutropenia: A Single-Centre Prospective Observational Study
por: Verlinden, Anke, et al.
Publicado: (2019)

Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions
por: Granacher, Nikki Charlotta Paul, et al.
Publicado: (2017)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

Reducing Repeat Blood Cultures in Febrile Neutropenia: A Single-Center Experience
por: Robinson, Evan D, et al.
Publicado: (2022)

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma
por: Roex, Gils, et al.
Publicado: (2020)

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
por: Anguille, Sébastien, et al.
Publicado: (2009)

Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases
por: Nordvig, Josefine, et al.
Publicado: (2018)

253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
por: Alegria, William, et al.
Publicado: (2018)

The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Andreatos, Nikolaos, et al.
Publicado: (2017)

Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
por: Hodgson-Viden, Heather, et al.
Publicado: (2005)

Next-Generation Sequencing to Detect Pathogens in Pediatric Febrile Neutropenia: A Single-Center Retrospective Study of 112 Cases
por: Horiba, Kazuhiro, et al.
Publicado: (2021)

Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey
por: Verlinden, Anke, et al.
Publicado: (2020)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Interferon α may be back on track to treat acute myeloid leukemia
por: Smits, Evelien L.J.M., et al.
Publicado: (2013)

Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia
por: Benamu, Esther, et al.
Publicado: (2021)

The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study
por: Aleissa, Muneerah M, et al.
Publicado: (2022)

Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia
por: Teofili, Luciana, et al.
Publicado: (2016)

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
por: Zimmer, Andrea J, et al.
Publicado: (2022)

A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2022)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics
por: Lappalainen, Marika, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia
por: Cerasi, Sara, et al.
Publicado: (2023)

The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation
por: Michiels, Jan Jacques, et al.
Publicado: (2014)

Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice
por: Weycker, Derek, et al.
Publicado: (2015)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia
por: Rearigh, Lindsey, et al.
Publicado: (2020)

Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
por: Mayer, Karin, et al.
Publicado: (2022)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
por: Lakshmaiah, Kuntegowdanahalli C, et al.
Publicado: (2015)

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013)

Corrigendum to “Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update”
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2019)

Soluble CD14 as a Diagnostic and Prognostic Biomarker in Hematological Patients with Febrile Neutropenia
por: Korpelainen, Sini, et al.
Publicado: (2017)

Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study
por: Kroloff, Maxwell, et al.
Publicado: (2022)

Variation in Clinical Practice and Attitudes on Antibacterial Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States
por: Barreto, Jason N, et al.
Publicado: (2022)

Antimicrobial de-escalation in patients with high-risk febrile neutropenia: Attitudes and practices of adult hospital care providers
por: Gorsline, Chelsea A., et al.
Publicado: (2021)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e57h3rtk51ha7k14r1nutcsshp